Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove People with Substance Use or Abuse Problems as Audience
- Remove Health Insurance Providers
- Remove HHS Staff
- Remove People with Mental Health Problems as Audience
- Remove Health Insurance
- Remove Treatment Improvement
- Remove Substance Abuse
- Remove Practitioner/Professional
- Remove Naloxone
- Remove Behavioral Therapy
- Remove Family Treatment Approach
Main page content
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: April 2018
This fact sheet serves as a guide for individuals seeking behavioral health treatment. It provides three necessary steps to complete prior to utilizing a treatment center and the five signs of a quality treatment center, which include a review of the accreditation, medication, evidence-based practices, position on the role of families, and support networks.